Fundraising FoxAngel Physicians Fund — Full Portfolio
44 tracked investments · listed companies and verified rows first
Alphyn Biologics develops Multi-Target Therapeutics based on its Zabalafin (AB-101) platform to treat skin diseases, with a lead candidate, zabalafin hydrogel, a non-steroidal topical treatment for atopic dermatitis in children and adults that targets itch, inflammation, and Staph bacteria.
BiotechHealthtechMedical DevicesAnnapolis, US
Jazmyne Mink(Co-founder & Regulatory Affairs Director)inGary Pekoe(Co-founder & Chief Scientific Officer)Neal Koller(Co-founder & CEO, Chairman of the Board)Steven Pentelnik(Co-founder & President)
Co-investorsQCA First
BiotechHealthtechSt. Paul, US
Joshua Woolley(Executive Officer)inRyan Gladney(Executive Officer)Gary Graham(Executive Officer)Dan W. Gladney(Executive Officer, Director)inPeter DeLange(Executive Officer)inBruce A. Machmeier(Executive Officer)
Co-investorsBrightstone Venture CapitalBroadview VenturesCatalyst Health VenturesPortfoliaXeraya CapitalBioStar Ventures
ARIZ Precision Medicine develops cancer treatments that combine biological and nanotechnology approaches to target the genetic and epigenetic drivers of cancer, aiming to kill cancer cells while leaving healthy cells undamaged.
BiotechDeep TechHealthtechDavis, US
Brad Niles(Chief Executive Officer)Glenn Kazo(Chief Business Officer)
BoardLonnie Bookbinder(Board Chairman)
Co-investorsMoneta Ventures
Armatus Bio develops vectorized RNA interference therapeutics targeting genetic neurological and neuromuscular diseases.
BiotechMedical Devices
Co-investorsCincyTech
Avive develops automated external defibrillators (AEDs) and cardiac emergency response systems designed to improve outcomes for sudden cardiac arrest.
Digital HealthHealthtechIoTMedical DevicesForsyth, US
Rory Beyer(President / Chief Operating Officer, Co-Founder)inMoseley Andrews(Co-Founder)inSameer Jafri(Chief Executive Officer, Co-Founder)in
Co-investorsCatalyst Health VenturesEckuityHealthtech CapitalIrishAngelsLaerdal Million Lives FundQuesta Capital+2 more
AZBio is a statewide industry association and advocate for Arizona's bioscience sector, connecting biotech, medtech, and healthcare organizations to support the state's life science ecosystem.
BiotechHealthtechMedical DevicesArizona, US
Co-investorsColorado BioScience Association
Banjo Health builds AI-driven software to automate and streamline the prior authorization process for health plans and pharmacy benefit managers (PBMs).
AI & Machine LearningDigital HealthHealthtechWashington, US
Saaransh Mahna(Executive Officer, Director, Promoter)
BoardGregory Epstein(Director)
Co-investorsEpsilon Health InvestorsTau VenturesTAU Ventures
Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration.
BiotechMedical Devices
Charles Sidoti(Founder)in
Co-investorsCatalyst Health VenturesExcelestar VenturesFemHealth VenturesSchooner CapitalSparta GroupSV Health Investors
Clint operates a clinical decision support platform that matches patients with evidence-based therapies by analyzing electronic health records and clinical guidelines at the point of care.
AI & Machine LearningDigital HealthHealthtechStanford, US
Co-investorsMedMountain Ventures
HealthtechNashua, US
Aaron V. Kaplan, MD(Executive Officer, Director)Aaron V. Kaplan(Executive Officer, Director)inAndy H. Levine(Executive Officer, Director)inJames Reinstein(Executive Officer, Director)in
BoardJoshua Phillips(Director)inScott Ward(Director)
Co-investorsExcelestar Ventures
Conkay Medical is a medical device company developing technologies focused on cardiovascular care.
HealthtechMedical Devices
Albert Yuan(Founder)in
Co-investorsUnorthodox Ventures
Cordance Medical develops medical technology focused on diagnosing and treating patients with brain diseases, drawing on expertise from neurosurgery, neuroimaging, and biomedical engineering.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesMountain View, US
Ryan Dittamore(CEO)in
Co-investorsBeresford VenturesBlack Mountain VentuesCreative Destruction Lab (CDL)Shanda GroupSmartGateVCSonder Capital+1 more
Elucid develops artificial intelligence technology that analyzes CT images to identify hidden features of cardiovascular risk and guide personalized treatment of coronary artery disease.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Blake Richards(Executive Officer)inKelly Huang(Executive Officer, Director)inRobert Braun(Director)
BoardEvan Melrose(Director)Rajesh Panda(Director)Michael Lesh(Director)
Co-investorsAphelion CapitalBlueStone Venture PartnersIAG Capital PartnersMedTex Ventures LLC
Enable Injections develops and manufactures enFuse, a wearable drug delivery device that delivers large volumes of pharmaceutical and biologic therapeutics subcutaneously for patients with chronic diseases.
BiotechHealthtechMedical DevicesCincinnati, US
Mike Hooven(Chairman, President and CEO)inTimothy Flaherty(Executive Officer)Simone Song(Director)Karen Robards(Director)Richard J D'Augustine(Director)Norman R. Weldon(Director)
Co-investorsCincyTechLightship CapitalOhio Innovation FundMagnetar AI VenturesVersant Ventures
Epitel is a digital health company that builds REMI, a wearable, wireless cloud-based EEG monitoring system with AI-based seizure event detection for use in healthcare and ambulatory settings.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSalt Lake City, US
Mark Lehmkuhle(CTO, Founder)inSteve Pacelli(CEO)in
Co-investorsCatalyst Health VenturesGenoa VenturesIdeashipMedMountain VenturesOSF VenturesStar51 Capital+1 more
CHV is a venture capital firm that invests in medical technology companies developing therapeutic devices, diagnostic tools, and digital health solutions to improve patient outcomes.
HealthtechMedical Devices
Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design.
Advanced ManufacturingBiotechHealthtechMedical DevicesSalt Lake City, US
Frank Maguire(Executive Officer, Director)
BoardKen Charhut(Director)George Wallace(Director)Morteza Gharib(Director)Mory Gharib(Director)
Co-investorsKairos Venture Investments, LlcMemorialCare Innovation FundBioStar CapitalBioStar VenturesKairos Venture PartnersSUMMATION HEALTH VENTURES
ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company developing immune therapies for immune-excluded tumors, which resist standard PD-1 blockade.
BiotechHealthtechMedical DevicesDoylestown, US
Michael A. Curran(Director)inJennifer Barlow(Executive Officer, Director)Clifford Stocks(Director)James Barlow(Executive Officer, Director)Jeremy Barton(Executive Officer)Federica O'Brien(Executive Officer)
Co-investors3Spoke CapitalAdit Ventures Management, LlcBioAdvanceCancer FocusService Provider CapitalTexas HALO Fund
Instylla develops resorbable liquid embolic agents for interventional radiology and oncology, including the Embrace Hydrogel Embolic System and the Tembo Embolic System used to embolize hypervascular tumors and occlude peripheral blood vessels.
BiotechHealthtechMedical DevicesBedford, US
Amarpreet Sawhney(Executive Officer)Raymond Lareau(Executive Officer)inSteven Cagnetta(Executive Officer)Sean Boyle(Chief Executive Officer)in
BoardHenry Chen(Director)inTasneem Dohadwala(Director)in
Co-investorsAscension VenturesCatalyst Health VenturesDelos CapitalExcelestar VenturesSparta Group
Therapeutics company with an active clinical development program.
The University of Minnesota is a public higher education institution offering undergraduate majors, graduate and professional degrees, and internship and research opportunities across fields including liberal arts and business.
EdTechMinneapolis, US
Co-investorsTraction Capital
MuReva Phototherapy develops oral phototherapy devices intended to reduce dose-limiting side effects, such as oral mucositis, in cancer patients undergoing radiation and chemotherapy.
Advanced ManufacturingHardwareHealthtechMedical DevicesBrecksville, US
Vedang Kothari(President)Sam Shelnutt(Vice-President of Engineering)inMichael Marotta(Vice President of Clinical Affairs)inPeter Broer(Director)Creighton Murch(Director)Austin Ruhle(Chief Financial Officer)
Co-investorsBand of AngelsJumpstart Ventures
OrisDX develops a non-invasive salivary-rinse DNA test called Oro Lesion to detect early markers of oral cavity squamous cell carcinoma in adults with indeterminate oral lesions.
BiotechDigital HealthMedical DevicesChicago, US
Harald Steltzer(Executive Officer, Director)inPatrick Conniff(Executive Officer)inEvgeny Izmchenko(Director)Nishant Agrawal(Director)in
Co-investorsHARPER COURT VENTURES
PanTher develops targeted cancer therapeutics that deliver drugs directly to tumor sites at high concentrations over extended periods, aiming to improve clinical outcomes while reducing side effects.
BiotechHealthtechMedical DevicesAustin, US
Laura Indolfi(Chief Executive Officer and Co-Founder)inElazer Edelman(Director)
BoardD Mackey(Director)inDaniel Wildman(Director)Darshana Zaveri(Director)Maria Palasis(Director)
Co-investorsCatalyst Health VenturesMission BiocapitalWalnut Venture Associates
This page is a distribution, marketing, and reseller partner directory for PRWeb, an online press release distribution service.
Marketing TechMedia & EntertainmentSaaS
Co-investorsAdvance Venture PartnersAvestria VenturesAviv Venture CapitalBIGR VenturesBlue Venture FundsBuoyant Ventures Management, Llc+15 more
Perceptive applies AI and robotics technology to dental practice, helping dentists increase patient capacity.
AI & Machine LearningHealthtechMedical DevicesRoboticsBoston, US
Chris Ciriello(Founder)inScott Phillips(Founder)inPhil Getto(CTO)inAlex Furleigh(Chief of Staff)in
Co-investorsC3 VenturesDIANecessary VenturesRevere PartnersTSVCY Combinator+10 more
Promaxo develops a compact, office-based MRI system designed for point-of-care use, with applications including image-guided prostate interventions.
BiotechHardwareHealthtechMedical DevicesOakland, US
Amit Vohra(Executive Officer, Director)inMichael Bartholomew(Executive Officer, Director)inDinesh Kumar(Executive Officer)in
BoardJonathan Chen(Director)Derek Hennecke(Director)inDushyant Chipalkatty(Director)
Co-investorsBand of AngelsFrontier Path VCZynext Ventures
S4 Medical develops the esolution device, a technology intended to protect the esophagus from ablation energy during cardiac ablation procedures.
HealthtechMedical Devices
Bill Fuller(CEO and Co-founder)inEmile Daoud(Co-founder, Chief Medical Officer, and Co-inventor)in
Co-investorsJumpstart VenturesOhio Innovation Fund
Sense Neuro Diagnostics is developing non-invasive technology to rapidly detect stroke subtype and traumatic brain injury and to continuously monitor brain injury, producing a scan in 2.5 seconds that analyzes the entire cranial vault.
Deep TechHealthtechMedical Devices
George "Chip" Shaw(Co-founder)
Simergent develops medical device systems for regulated healthcare markets, with expertise in peritoneal dialysis and infusion pump technologies.
BiotechHealthtechMedical DevicesChicago, US
Steve J. Lindo(Co-founder & CEO)inRick Pendergraft(Co-founder & Chief Technology Officer)inDr. James Sloand(Chief Medical Officer)Michael Rohleder(Manager)
Co-investorsPathway BioventuresPlains Ventures
Spect provides automated retinal screening to detect conditions like diabetic retinopathy and glaucoma in primary care settings, reducing the need for manual assessment by eye specialists.
AI & Machine LearningHealthtechWellness & FitnessSan Francisco, US
Ankur Gupta(Founder)inRishab Gargeya(Founder)inTed Leng(Founder)in
Co-investorsTaver CapitalY CombinatorMorado VenturesSeed Round Capital
Sword Bio is a bioanalytical contract research organization providing assay development and testing services for pharmaceutical and biotechnology companies across preclinical through Phase IV clinical trials.
BiotechEnterprise SoftwareHealthtechMedical Devices
Dave Dingott(CEO and Founder)in
Co-investorsElevate Ventures
Tombot creates animatronic robotic pets designed to provide companionship and therapeutic benefits for people who cannot care for live animals, with initial focus on treating behavioral and psychological symptoms in older adults with dementia.
HealthtechMedical DevicesMental HealthRoboticsValencia, US
Tom Stevens(CEO and Co-Founder)in
Co-investorsCaduceus Capital PartnersJumpstart FoundryWavemaker Three-Sixty Health
TPA Stream provides invoicing software for benefits and medical third-party administrators (TPAs), consolidating scattered billing and admin data into employer invoices using existing systems.
HealthtechInsurTechSaaSShaker Heights, US
Jacob Sheridan(Executive Officer, Director)Stephen Fuhry(Founder)inEric Sukalac(Executive Officer, Director)
BoardBill Fisher(Director)Mark Peterson(Director)Clay Rankin(Director)
Co-investorsJumpstart VenturesService Provider CapitalTamiami Angel
Valitor develops bioactive molecule therapies using a multivalent biopolymer technology platform to create long-acting treatments for ophthalmologic diseases, with its lead candidate VLTR-559 targeting wet age-related macular degeneration.
BiotechMedical DevicesBerkeley, US
Wesley Jackson(President, Chief Scientific Officer & Member of the Board)inGregory D. Kunst(Chief Executive Officer)Carole H Bellis(Executive Officer)Kevin E Healy(Director)Jackson M Wesley(Executive Officer, Director)
BoardDrew Lanza(Director)in
Co-investorsBerkeley CatalystExSight VenturesFirst Spark Ventures, LlcPandect BioventuresTaihill Venture
VITRUVIAE is a biotechnology company developing cancer immunotherapies that target sugars and lipids found on tumor cells but not on healthy cells, aiming to improve tumor selectivity and counter drug resistance.
BiotechDeep TechHealthtechNutley, US
Sonia Sequeira(Chief Executive Officer (CEO), founder)inMahiuddin Ahmed(President and Chief Scientific Officer (CSO))in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BlinkpadBrixton BioESGEyecoolFemtoVoxMuReva Photodynamic TherapyOphthalmologytimesPerceptive DentalRosenmaninstituteSense Neuro DiagnositicsTargetedonc
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.